Form 483

Kabco Pharmaceuticals, Inc. Form 483, 2013-04-12

FDA issued a Form 483 to Kabco Pharmaceuticals, Inc. on 2013-04-12 with 8 public-safe observations.

483· Form 483 issuedFoods & Cosmetics8 observations

Kabco Pharmaceuticals, Inc. · Amityville, United States · Issued April 12, 2013

Overview

  • 8 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Apr 2013
21 CFR 111.75(a)(1)(i)

Component - verify identity, dietary ingredient

Cited by Meredith P Soehl, Sarah A Meehan, Ann M Stewart

12 Apr 2013
21 CFR 111.75(a)(2)(ii)(A)

Component - qualify supplier

Cited by Meredith P Soehl, Sarah A Meehan, Ann M Stewart

12 Apr 2013
21 CFR 111.75(c)

Specifications met - verify; finished batch

Cited by Meredith P Soehl, Sarah A Meehan, Ann M Stewart

12 Apr 2013
21 CFR 111.75(h)(2)

Tests, examinations - scientifically valid

Cited by Meredith P Soehl, Sarah A Meehan, Ann M Stewart

12 Apr 2013
21 CFR 111.90(b)(1)

Reprocessed, dietary supplement - no material review

Cited by Meredith P Soehl, Sarah A Meehan, Ann M Stewart

Inspected site

KPKabco Pharmaceuticals, Inc.Amityville, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.205(a)Cited across public-safe Form 483 observations1x
21 CFR 111.210(g)Cited across public-safe Form 483 observations1x
21 CFR 111.560(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.75(a)(1)(i)Cited across public-safe Form 483 observations1x
21 CFR 111.75(a)(2)(ii)(A)Cited across public-safe Form 483 observations1x
21 CFR 111.75(c)Cited across public-safe Form 483 observations1x
21 CFR 111.75(h)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.90(b)(1)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 8 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere